Clinical Trial Update: Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the Lungs [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of interferon-gamma on cavitary pulmonary tuberculosis; the study completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Tuberculosis

Drugs mentioned

• Interferon-gamma (interferon gamma)

Snippet

Sponsor: NYU Langone Health | Conditions: Tuberculosis, AIDS-related Complex | Phase 2 | Status: COMPLETED | Results posted: 2014-06-10